Search

Your search keyword '"Tsurumi T"' showing total 477 results

Search Constraints

Start Over You searched for: Author "Tsurumi T" Remove constraint Author: "Tsurumi T"
477 results on '"Tsurumi T"'

Search Results

301. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.

302. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.

303. Characterization of the UL55 gene product of herpes simplex virus type 2.

304. Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase.

305. Overexpression, purification and helix-destabilizing properties of Epstein-Barr virus ssDNA-binding protein.

306. [Thoracoscopic limited resection for lung cancer].

307. Subcellular localization of the US3 protein kinase of herpes simplex virus type 2.

308. The product of the US10 gene of herpes simplex virus type 1 is a capsid/tegument-associated phosphoprotein which copurifies with the nuclear matrix.

309. Strand displacement associated DNA synthesis catalyzed by the Epstein-Barr virus DNA polymerase.

310. Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2.

311. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].

312. Calnexin associates with the precursors of glycoproteins B, C, and D of herpes simplex virus type 1.

313. Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase.

314. Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.

315. The US3 protein kinase of herpes simplex virus type 2 is associated with phosphorylation of the UL12 alkaline nuclease in vitro.

316. Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.

318. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages.

319. Identification of a target protein of US3 protein kinase of herpes simplex virus type 2.

320. Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3'-to-5' exonucleolytic activity and stability of initiation complex at primer terminus.

321. Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence.

322. Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro.

323. Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2.

324. Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit.

325. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system.

326. The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice.

327. [Herpes simplex virus DNA replication].

328. Selective inhibition of the 3'-to-5' exonuclease activity associated with Epstein-Barr virus DNA polymerase by ribonucleoside 5'-monophosphates.

329. Relationship between tumor DNA ploidy and regional lymph node changes in lung cancer.

330. [Operation of pleural dissemination of thymoma].

331. Primer terminus recognition and highly processive replication by Epstein-Barr virus DNA polymerase.

332. Characterization of 3'-to 5'-exonuclease activity associated with Epstein-Barr virus DNA polymerase.

333. Prognostic implications of DNA histogram, DNA content, and histologic changes of regional lymph nodes in patients with lung cancer.

334. [Surgical treatment of bullous emphysema using Gore-Tex sheet].

335. Ionic strength affects diffusive permeability to an inorganic phosphate ion of negatively charged dialysis membranes.

336. An attempt to prepare hepatitis B virus (HBV)-free plasma by ultrafiltration using microporous regenerated cellulose hollow fiber.

337. Release of RNA polymerase from vero cell mitochondria after herpes simplex virus type 1 infection.

339. A case of chronic pancreatitis successfully treated by endoscopic removal of protein plugs.

340. Diagnosis of carcinoma of the papilla of Vater by duodenofiberscopy: simultaneous attempt on endoscopic observation, aspiration cytology, retrograde pancreatocholangiography and biopsy.

341. Heat(40 degrees C)-induced polypeptides in human embryonic fibroblasts.

342. Effect of splenectomy and immunotherapy on advanced gastric cancer associated with total gastrectomy.

343. A novel method for removal of human immunodeficiency virus: filtration with porous polymeric membranes.

344. Effects of zeta potential on the permeability of dialysis membranes to inorganic phosphate.

345. Development of a regenerated cellulose non-complement activating membrane for hemodialysis.

346. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.

348. [Experimental and clinical studies of bestatin as an immunomodulator].

350. Analysis of the inhibitory effect of canavanine on the replication of influenza RI/5+ virus. II. Interaction of M protein with the plasma membrane.

Catalog

Books, media, physical & digital resources